樂觀
$14.87
情境價格
$10.440
-0.366 (-3.51%)收盤時
Alphatec Holdings, Inc., through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical device company. It is focused on the design, development, and advancement of technology for better surgical treatment of spine disorders. Its Organic Innovation Machine is focused on developing new approaches that integrate with its expanding InformatiX Platform to better inform surgery and safely and reproducibly achieve the goals of spine surgery. Its technologies include InformatiX, positioners, access systems, implants and fixation systems, and biologics. Its InformatiX product platform comprises EOS imaging system, EOS Insight alignment assessment and surgical planning web/mobile platform, SafeOp Neural InformatiX System and navigation-enabled robotics platform. It has developed approach-specific patient positioning systems that integrate with its other access systems, providing for a more rigid construct and enhanced reproducibility.
Alphatec Holdings Inc (ATEC) is a good buy right now due to its current price of $10.67, which is below the analyst price targets ranging from $12 to $15. The stock has shown a recent 5-day change of +6.38%, indicating positive momentum, and the RSI is at 62.93, suggesting it is not overbought. However, the company has a significant risk with a forward P/E ratio of 18.55, indicating potential overvaluation concerns if earnings do not improve.
BMO Capital
$12
2026-08-05
BMO Capital
2026-08-05
目標價
$12
UBS
$15
2026-07-28
UBS
2026-07-28
目標價
$15
Stephens
$15
2026-07-23
Stephens
2026-07-23
目標價
$15
Stifel
$13
2026-07-08
Stifel
2026-07-08
目標價
$13
Barclays
$24
2026-05-07
Barclays
2026-05-07
目標價
$24
情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

Alphatec CEO's Stock Purchase Signals Confidence

Alphatec CEO's Stock Purchase Signals Confidence

ATEC Appoints New Executive to Advance Data Strategy

Alphatec (ATEC) Q2 2026 Earnings Call Transcript

Alphatec Holdings Q2 2026 Earnings Highlights
Alphatec Holdings, Inc., through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical device company. It is focused on the design, development, and advancement of technology for better surgical treatment of spine disorders. Its Organic Innovation Machine is focused on developing new approaches that integrate with its expanding InformatiX Platform to better inform surgery and safely and reproducibly achieve the goals of spine surgery. Its technologies include InformatiX, positioners, access systems, implants and fixation systems, and biologics. Its InformatiX product platform comprises EOS imaging system, EOS Insight alignment assessment and surgical planning web/mobile platform, SafeOp Neural InformatiX System and navigation-enabled robotics platform. It has developed approach-specific patient positioning systems that integrate with its other access systems, providing for a more rigid construct and enhanced reproducibility. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).
Alphatec Holdings Inc (ATEC) is a good buy right now due to its current price of $10.67, which is below the analyst price targets ranging from $12 to $15. The stock has shown a recent 5-day change of +6.38%, indicating positive momentum, and the RSI is at 62.93, suggesting it is not overbought. However, the company has a significant risk with a forward P/E ratio of 18.55, indicating potential overvaluation concerns if earnings do not improve.
3 analysts cover ATEC: 2 rate it Buy, 1 Hold and 0 Sell. The average price target is 24.33.
暫無貼文
註冊或登入後參與討論本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。